Fundraising FoxAlta Partners — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
Allakos Incallakos.comDec 2012 · $10M
Portfolio company that completed a successful 2018 biotech IPO, resulting in a 9x return for RiverVest.
BiotechSan Carlos, US
Nenad Tomasevic(Executive Officer)Christopher Bebbington(Executive Officer, Director)Alejandro Dorenbaum(Executive Officer)
BoardJohn McKearn(Director)inPeter Moldt(Director)
Board seatDan JanneyFarah Champsi· per SEC Form D
Co-investorsLifeSci Venture PartnersNew Enterprise Associates (NEA)RiverVest Venture PartnersRoche Venture FundSamsara BioCapital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.